Cyclic Triazole Compounds for Central Anti-Inflammatory Activity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing anti-inflammatory compounds do not effectively address the inflammatory processes associated with psychiatric and neurodegenerative diseases, lacking properties such as anti-inflammatory activity, bioavailability, solubility, cell membrane permeability, and safety.
Innovation Solution
Development of specific chemical compounds and pharmacologically acceptable salts with a novel structure, including 1,2,4-triazole derivatives, which exhibit enhanced anti-inflammatory activity, bioavailability, and improved safety profiles for treating inflammatory diseases.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If existing anti-inflammatory compounds are used, then they have known pharmacological properties, but they lack effective anti-inflammatory activity against psychiatric and neurodegenerative diseases
Solution Approach 1:
The patent applies parameter changes by systematically modifying the chemical structure of triazole derivatives, specifically varying substituents at positions R1, R2, R3, R4, and R5 to optimize anti-inflammatory activity. The invention identifies specific structural parameters (such as aromatic heterocyclic groups, cycloalkyl groups, and their substitution patterns) that enhance effectiveness against central nervous system inflammation while maintaining peripheral anti-inflammatory properties.
Solution Approach 2:
The patent employs composite material principles by creating compounds with multiple functional groups combined in a single molecule. The triazole core structure is复合 with various aromatic heterocyclic groups, cycloalkyl groups, and substituent patterns to achieve multi-target activity against both peripheral and central inflammatory pathways, thereby addressing both psychiatric and neurodegenerative conditions.
2Reliability
If novel compound structures are developed, then anti-inflammatory activity and bioavailability are improved, but safety concerns may arise
Solution Approach 1:
The patent applies self-service principles by designing compounds with metabolic stability features that allow the body to process and eliminate the drug through normal physiological pathways. The specific structural configuration of the triazole derivatives enables appropriate metabolism and excretion, ensuring that improved bioavailability does not lead to toxic accumulation.
3Duration of action of moving object
If existing compounds are used, then they have established safety profiles, but they lack rapid onset and sustained efficacy
Solution Approach 1:
The patent applies dynamics principles by creating compounds with optimized pharmacokinetic properties that enable both rapid absorption and sustained release. The molecular structure is designed to achieve appropriate solubility and membrane permeability for rapid onset, while metabolic stability ensures sustained efficacy over time.
Data Source
Figure 1~2
Figure 3~4
Figure 5~6
AI summary
An object of the present invention is to provide a compound having an anti-inflammatory activity or a pharmacologically acceptable salt thereof. The solution of the present invention is a compound of general formula (1) or a pharmacologically acceptable salt thereof. wherein the symbols in the formula are defined below: A: e.g., Benzene, E: e.g., -CH2-, G: e.g., a 5-membered aromatic heterocyclic ring, X: e.g., cyclohexane, J: e.g., a 5-membered aromatic heterocyclic ring, Y: e.g., a phenyl group, R1, R2, R3: e.g., a halogen atom, R4: e.g., a C1-C6 alkyl group, R5: e.g., a hydrogen atom, R6a, R6b, R6c, R6d: e.g., a hydrogen atom, R7: e.g., a hydrogen atom, R8: e.g., a hydrogen atom, n1, n2, n3: e.g., 1.